ResMed Gross Profit 2010-2025 | RMD
ResMed annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- ResMed gross profit for the quarter ending March 31, 2025 was $0.766B, a 10.63% increase year-over-year.
- ResMed gross profit for the twelve months ending March 31, 2025 was $2.950B, a 15.38% increase year-over-year.
- ResMed annual gross profit for 2024 was $2.655B, a 12.72% increase from 2023.
- ResMed annual gross profit for 2023 was $2.356B, a 16.37% increase from 2022.
- ResMed annual gross profit for 2022 was $2.024B, a 10.07% increase from 2021.
| ResMed Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $2,655 |
| 2023 | $2,356 |
| 2022 | $2,024 |
| 2021 | $1,839 |
| 2020 | $1,718 |
| 2019 | $1,494 |
| 2018 | $1,335 |
| 2017 | $1,202 |
| 2016 | $1,066 |
| 2015 | $1,011 |
| 2014 | $990 |
| 2013 | $941 |
| 2012 | $821 |
| 2011 | $741 |
| 2010 | $655 |
| 2009 | $554 |
| ResMed Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $766 |
| 2024-12-31 | $751 |
| 2024-09-30 | $717 |
| 2024-06-30 | $716 |
| 2024-03-31 | $693 |
| 2023-12-31 | $647 |
| 2023-09-30 | $600 |
| 2023-06-30 | $617 |
| 2023-03-31 | $618 |
| 2022-12-31 | $580 |
| 2022-09-30 | $541 |
| 2022-06-30 | $523 |
| 2022-03-31 | $491 |
| 2021-12-31 | $504 |
| 2021-09-30 | $506 |
| 2021-06-30 | $491 |
| 2021-03-31 | $447 |
| 2020-12-31 | $462 |
| 2020-09-30 | $439 |
| 2020-06-30 | $449 |
| 2020-03-31 | $450 |
| 2019-12-31 | $427 |
| 2019-09-30 | $392 |
| 2019-06-30 | $395 |
| 2019-03-31 | $381 |
| 2018-12-31 | $375 |
| 2018-09-30 | $343 |
| 2018-06-30 | $335 |
| 2018-03-31 | $344 |
| 2017-12-31 | $350 |
| 2017-09-30 | $306 |
| 2017-06-30 | $324 |
| 2017-03-31 | $300 |
| 2016-12-31 | $309 |
| 2016-09-30 | $269 |
| 2016-06-30 | $301 |
| 2016-03-31 | $260 |
| 2015-12-31 | $267 |
| 2015-09-30 | $239 |
| 2015-06-30 | $259 |
| 2015-03-31 | $251 |
| 2014-12-31 | $263 |
| 2014-09-30 | $237 |
| 2014-06-30 | $261 |
| 2014-03-31 | $252 |
| 2013-12-31 | $249 |
| 2013-09-30 | $228 |
| 2013-06-30 | $260 |
| 2013-03-31 | $239 |
| 2012-12-31 | $233 |
| 2012-09-30 | $209 |
| 2012-06-30 | $226 |
| 2012-03-31 | $210 |
| 2011-12-31 | $199 |
| 2011-09-30 | $185 |
| 2011-06-30 | $199 |
| 2011-03-31 | $183 |
| 2010-12-31 | $186 |
| 2010-09-30 | $174 |
| 2010-06-30 | $175 |
| 2010-03-31 | $167 |
| 2009-12-31 | $164 |
| 2009-09-30 | $150 |
| 2009-06-30 | $157 |
| 2009-03-31 | $139 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.519B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Medtronic (MDT) | Ireland | $113.223B | 16.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Koninklijke Philips (PHG) | Netherlands | $23.611B | 16.57 |
| Insulet (PODD) | United States | $21.226B | 83.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |